Lv3
280 积分 2025-11-07 加入
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
1个月前
已完结
MASLD prevalence, incidence and global aspects
1个月前
已完结
CMTM6 promotes radioresistance in hepatocellular carcinoma via EMT induction and synergistic interaction with VEGFA
1个月前
已完结
Natural molecule isoliquiritigenin mitigates MASH and liver fibrosis in mice by promoting autophagy through the PI3K/Akt signaling pathway
1个月前
已完结
Mulberry Leaf Alkaloids and Their Main Component 1-Deoxynojirimycin Mitigate CDAHFD-Induced Metabolic Dysfunction-Associated Steatohepatitis by Promoting Autophagy through the PI3K/AKT/mTOR Pathway
1个月前
已完结
Prevotella ‐Derived Butyrate Inhibits CD8 + T‐Cell Glycolysis via AKT / mTOR Signalling to Alleviate MASH
1个月前
已完结
Byakangelicin alleviates metabolic dysfunction-associated steatohepatitis by selective inhibition of non-canonical MTORC1 signaling pathway
1个月前
已完结
Insulin plant (Costus igneus) extract alleviates steatosis and adiposity in a murine MASLD model by modulating hepatic lipogenesis and the CD9-CFD immunoregulatory axis
1个月前
已关闭
Knockdown of suppressor of glucose by autophagy (SOGA1) alleviates the progression of non-alcoholic steatohepatitis (NASH) by reducing hepatocyte senescence through regulating AMPK/mTOR-mediated mitochondrial homeostasis
1个月前
已完结
β-Sitosterol ameliorates metabolic dysfunction-associated steatohepatitis by targeting the RAC1/mTOR/TFEB axis thus activating lipophagy-lysosomal pathway
3个月前
已完结
皖公网安备34019202002308
